Caricamento...
Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
PURPOSE: The aim of this study is to investigate the effect of hepatic or renal impairment on the pharmacokinetics of a single 130-mg evacetrapib dose. METHODS: Two open-label, parallel-design studies in males and females with normal hepatic function or Child-Pugh mild, moderate, or severe hepatic i...
Salvato in:
| Pubblicato in: | Eur J Clin Pharmacol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834099/ https://ncbi.nlm.nih.gov/pubmed/26857125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-016-2017-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|